New arthritis drug monitored for safety in real patients
NCT ID NCT03885037
Summary
This study collected information on the safety and effectiveness of a biosimilar version of an existing rheumatoid arthritis drug when used in regular medical practice. It involved 77 patients with rheumatoid arthritis who were starting treatment with this specific medication. The goal was to understand how the drug performs and what side effects might occur outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Local Country Office
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.